Press release

Free for publication on September 27, 2019 at 4:00 pm (CEST +1)

Bittium and Cerenion exhibit next-generation brain monitoring solution to intensive care at ESICM Lives 2019

Oulu, Finland, September 27, 2019 – Bittium and Cerenion exhibit their innovative products and solutions for intensive care and neurology at the 32nd annual congress of the European Society of Intensive Care Medicine (ESICM Lives 2019) in Berlin, Germany on September 29th – October 2nd 2019. The annual congress holds a premier spot as the meeting place for medical professionals and industry in the field of intensive care medicine. The congress, consisting of a strong scientific program, a well-attended industry exhibition and a range of training sessions is expected to again attract an audience of over 6,000 physicians, anesthetists, trainees and nursing and allied health professionals from around 100 countries all across the world.

At the event Bittium and Cerenion will present a comprehensive solution being developed in collaboration for monitoring the electrical activity of the brain (EEG) of intensive care patients. This is done by combining Bittium BrainStatus™, a wireless EEG-monitoring device designed for monitoring real-time electrical brain activity, with Cerenion’s innovative C-Trend™ analysis that helps to interpret the brain function of intensive care patients using one simple C-Trend™ Index, which is easy to follow. The solution eases and speeds up the work of the nursing staff at the intensive care unit.

Products and solutions exhibited at the event are:

• Bittium BrainStatus is a wireless compact EEG amplifier, which is used together with a disposable easy and quick to wear Bittium BrainStatus electrode headband, for example to diagnose epileptic seizures and brain stroke. Bittium BrainStatus enables quick measurement in field conditions as well as in hospitals, thus making the treatment process of the patient faster. Bittium BrainStatus can be used for wireless real-time remote EEG monitoring or data can be recorded in the device memory.
• Bittium BrainStatus with Cerenion C-Trend is the world’s first practical method for measuring the brain function of intensive care patients. C-Trend technology aims to reveal the status of the brain as one simple and easy to interpret score. Bittium BrainStatus measures and monitors the EEG signal and C-Trend interprets the signal to a simple score by using advanced machine learning algorithms and artificial intelligence.

More information on the offering: https://www.bittium.com/medical

Further information:

Arto Pietilä
Senior Vice President, Medical Technologies
Tel. +358 40 344 3507

Distribution:
Main media

Bittium

Bittium specializes in the development of reliable, secure communications and connectivity solutions, leveraging its 30 year legacy of expertise in advanced radio communication technologies. Bittium provides innovative products and services, customized solutions based on its product platforms and R&D services. In the field of healthcare technology, Bittium offers solutions for the measurement and monitoring of biosignals in the areas of cardiology, neurophysiology, rehabilitation, occupational health and sports medicine. Net sales in 2018 were EUR 62.8 million and operating profit was EUR 2.8 million. Bittium is listed on Nasdaq Helsinki. www.bittium.com